Competition Commission of India clears Kotak-Biocon Biologics deal

The investment will help Biocon Biologics' acquisition of the biosimilars business of its partner Viatris.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NZCQbhp
via IFTTT